You are here:
Home
NICE Guidance
Conditions and diseases
Diabetes and other endocrinal, nutritional and metabolic conditions
Osteoporosis
Setrusumab for treating osteogenesis imperfecta [TSID12308]
Awaiting development
Reference number:
GID-TA11921
Expected publication date: TBC
Project information
Project documents
7023-Setrusumab-for-Osteogenesis-Imperfecta-V1.0-OCT2025-NON-CONF-.pdf
Back to top